(Q43621563)

25 November 2017

Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. (English)

1 reference

25 November 2017

Dhanak D

1

1 reference

25 November 2017

Christmann LT

2

1 reference

25 November 2017

Darcy MG

3

1 reference

25 November 2017

Keenan RM

4

1 reference

25 November 2017

Knight SD

5

1 reference

25 November 2017

Lee J

6

1 reference

25 November 2017

Ridgers LH

7

1 reference

25 November 2017

Sarau HM

8

1 reference

25 November 2017

Shah DH

9

1 reference

25 November 2017

White JR

10

1 reference

25 November 2017

Zhang L

11

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

25 November 2017

1 reference

25 November 2017

11

1 reference

25 November 2017

11

1 reference

25 November 2017

1445-1450

1 reference

Chemokine receptors and their role in leukocyte activation.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Chemokines: understanding their role in T-lymphocyte biology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Human chemokines: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Eotaxin: what we know, and what we would like to know

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Cloning, expression, and characterization of the human eosinophil eotaxin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Opportunities for novel therapeutic agents acting at chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

A model for compounds active against human rhinovirus-14 based on X-ray crystallography data

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

An alternative synthesis of peptidyl alpha-keto-2-oxazolines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

The chemistry of Pseudomonic acid. 15. Synthesis and antibacterial activity of a series of 5-alkyl, 5-alkenyl, and 5-heterosubstituted oxazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Antirhinoviral activity of heterocyclic analogs of Win 54954

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

Conformational and topographical considerations in the design of biologically active peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900249-9

7 January 2021

10.1016/S0960-894X(01)00249-9

Identifiers

DOI

1 reference

25 November 2017

1 reference